Boxer Capital, LLC Codiak Bio Sciences, Inc. Transaction History

Boxer Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.82 - $3.19 $296,764 - $1.15 Million	-361,908 Reduced 42.57%	488,157 $382,000
Q4 2021 Feb 14, 2022	SELL	$10.0 - $16.78 $1.8 Million - $3.02 Million	-180,000 Reduced 17.47%	850,065 $9.47 Million
Q1 2021 May 17, 2021	BUY	$13.49 - $31.53 $5.77 Million - $13.5 Million	427,415 Added 70.92%	1,030,065 $15.5 Million
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $4.76 Million - $19.5 Million	602,650 New	602,650 $19.5 Million

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Boxer Capital, LLC with notifications on news.